Cargando…
SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192089/ https://www.ncbi.nlm.nih.gov/pubmed/34119033 http://dx.doi.org/10.1016/S2468-1253(21)00194-1 |
| _version_ | 1783705982868652032 |
|---|---|
| author | Alexander, James L Kennedy, Nicholas A Lees, Charlie W Ahmad, Tariq Powell, Nick |
| author_facet | Alexander, James L Kennedy, Nicholas A Lees, Charlie W Ahmad, Tariq Powell, Nick |
| author_sort | Alexander, James L |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8192089 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81920892021-06-11 SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply Alexander, James L Kennedy, Nicholas A Lees, Charlie W Ahmad, Tariq Powell, Nick Lancet Gastroenterol Hepatol Correspondence Elsevier Ltd. 2021-07 2021-06-10 /pmc/articles/PMC8192089/ /pubmed/34119033 http://dx.doi.org/10.1016/S2468-1253(21)00194-1 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Alexander, James L Kennedy, Nicholas A Lees, Charlie W Ahmad, Tariq Powell, Nick SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply |
| title | SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply |
| title_full | SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply |
| title_fullStr | SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply |
| title_full_unstemmed | SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply |
| title_short | SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply |
| title_sort | sars-cov-2 vaccination for patients with inflammatory bowel disease – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192089/ https://www.ncbi.nlm.nih.gov/pubmed/34119033 http://dx.doi.org/10.1016/S2468-1253(21)00194-1 |
| work_keys_str_mv | AT alexanderjamesl sarscov2vaccinationforpatientswithinflammatoryboweldiseaseauthorsreply AT kennedynicholasa sarscov2vaccinationforpatientswithinflammatoryboweldiseaseauthorsreply AT leescharliew sarscov2vaccinationforpatientswithinflammatoryboweldiseaseauthorsreply AT ahmadtariq sarscov2vaccinationforpatientswithinflammatoryboweldiseaseauthorsreply AT powellnick sarscov2vaccinationforpatientswithinflammatoryboweldiseaseauthorsreply AT sarscov2vaccinationforpatientswithinflammatoryboweldiseaseauthorsreply |